Depression in the patient with brain cancer

Community Oncology

Volumn 4, Issue 9, 2007, Pages 533-539

  Pangilinan Jr , Percival H ^a,b   Kelly, Brian M ^a,b   Pangilinan, Joanna Maudlin ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER THERAPY; COPING BEHAVIOR; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GROUP THERAPY; HUMAN; INCIDENCE; MORBIDITY; PREDICTOR VARIABLE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; TUMOR LOCALIZATION;

EID: 35349005177     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1548-5315(11)70030-4     Document Type: Review

References (22)

1. Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients. Psychooncology 2002;11:230-238.
2. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncology 2002;57:41-49.
3. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 1999;13:480-485.
4. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr; Glioma Outcomes Project Investigators. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 2004;54:358-366.
5. Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 2005;56:1234-1241.
6. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 2005;103:841-847.
7. Ryan H, Schofield P, Cockburn J, et al. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care (Engl) 2005;14:7-15.
8. Giovagnoli AR. Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour. J Neurol Neurosurg Psychiatry 1999;67:358-363.
9. Irle E, Peper M, Wowra B, Kunze S. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol 1994;51:164-174.
10. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol 2005;28:173-179.
11. Jenkins CA, Bruera, E. Difficulties in diagnosing neuropsychiatric complications of corticosteroids in advanced cancer patients: two case reports. J Pain Symptom Manage 2000;19:309-317.
12. Malek-Ahmadi P. Mood disorders associated with interferon treatment: theoretical and practical considerations. Ann Pharmacother 2001;35:489-495.
13. Schwenk TL. Cancer and depression. Prim Care 1998;25:505-513.
14. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52:89-99.
15. Beck A, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. New York, NY: The Psychological Corporation; 1996.
16. Fisch MJ, Loehrer PJ, Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 2003;21:1937-1943.
17. Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 2003;21:4635-4641.
18. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 2006;94:372-390.
19. McEvoy GK, ed. In: American Hospital Formulary Service Drug Information 2006. Bethesda, MD: American Society of Health-System Pharmacists; 2006.
20. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522-2527.
21. Shaw EG, Rosdhal R, D'Agostino RB Jr, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on congnitive function, mood, and quality of life. J Clin Oncol 2006;24:1415-1420.
22. Greeson JM, Sanford B, Monti DA. St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl) 2001;153:402-414.